activins has been researched along with Sarcopenia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ikizler, TA; Terker, AS | 1 |
| Achison, M; Adamson, S; Akpan, A; Aspray, T; Avenell, A; Band, MM; Bashir, T; Burton, LA; Cvoro, V; Donnan, PT; Duncan, GW; George, J; Gordon, AL; Gregson, CL; Hapca, A; Hume, C; Jackson, TA; Kemp, PR; Kerr, S; Kilgour, A; Masud, T; McKenzie, A; McKenzie, E; Patel, H; Pilvinyte, K; Roberts, HC; Rossios, C; Sayer, AA; Smith, KT; Soiza, RL; Steves, CJ; Struthers, AD; Tiwari, D; Whitney, J; Witham, MD | 1 |
| Barisione, C; Garibotto, G; Koppe, L; Picciotto, D; Verzola, D | 1 |
| Bachl, N; Franzke, B; Halper, B; Hofmann, M; Oesen, S; Ploder, M; Quittan, M; Strasser, EM; Stuparits, P; Tschan, H; Wagner, KH; Wessner, B | 1 |
| Kalinkovich, A; Livshits, G | 1 |
| Chakkalakal, JV; Krolewski, JJ; Nastiuk, KL; Pan, C; Sahasrabudhe, DM; Singh, S | 1 |
| Arounleut, P; Bowser, M; Fulzele, S; Hamrick, MW; Herberg, S; Hill, WD; Isales, CM; Shi, X | 1 |
2 review(s) available for activins and Sarcopenia
| Article | Year |
|---|---|
Emerging role of myostatin and its inhibition in the setting of chronic kidney disease.
Topics: Activin Receptors, Type II; Activins; Anabolic Agents; Animals; Clinical Trials as Topic; Disease Models, Animal; Exercise Therapy; Feeding Behavior; Humans; Muscle, Skeletal; Myostatin; Proteolysis; Renal Insufficiency, Chronic; Sarcopenia; Signal Transduction; Treatment Outcome | 2019 |
Sarcopenia--The search for emerging biomarkers.
Topics: Activins; Aging; Animals; Biomarkers; Brain-Derived Neurotrophic Factor; Growth Differentiation Factor 15; Humans; Myostatin; Sarcopenia | 2015 |
1 trial(s) available for activins and Sarcopenia
| Article | Year |
|---|---|
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial.
Topics: Activin Receptors; Activins; Aged; Body Composition; Cross-Sectional Studies; Female; Humans; Male; Muscle, Skeletal; Myostatin; Sarcopenia | 2023 |
4 other study(ies) available for activins and Sarcopenia
| Article | Year |
|---|---|
Untangling the fibers of sarcopenia: activin A in chronic kidney disease-associated muscle wasting.
Topics: Activins; Humans; Muscles; Muscular Atrophy; Renal Insufficiency, Chronic; Sarcopenia | 2022 |
Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.
Topics: Activins; Adult; Age Factors; Aged; Aged, 80 and over; Austria; Biomarkers; Body Composition; Comorbidity; Female; Follistatin; Growth Differentiation Factor 15; Humans; Insulin-Like Growth Factor I; Muscular Atrophy; Myostatin; Physical Examination; Regression Analysis; Sarcopenia; TGF-beta Superfamily Proteins; Young Adult | 2015 |
TGFβ Superfamily Members Mediate Androgen Deprivation Therapy-Induced Obese Frailty in Male Mice.
Topics: Activin Receptors, Type II; Activins; Animals; Bone Morphogenetic Proteins; Castration; Growth Differentiation Factors; Male; Mice; Mice, Inbred C57BL; Muscle Strength; Myostatin; Obesity; Sarcopenia; Transforming Growth Factor beta | 2016 |
Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells.
Topics: Activins; Aging; Animals; Bone Regeneration; Calcification, Physiologic; Cell Differentiation; Cell Proliferation; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Follistatin; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Muscle Fibers, Fast-Twitch; Muscle Fibers, Slow-Twitch; Myoblasts, Skeletal; Myostatin; Sarcopenia; Signal Transduction; Time Factors | 2013 |